Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1976-8-2
pubmed:abstractText
Both pregnenolone and 17-OH-pregnenolone were found to be higher in the plasma of patients with poorly controlled congential adrenal hyperplasia than in normal subjects. The plasma levels of these precursor steroids were significantly correlated with urinary 17-ketosteroid and pregnanetriol excretion and with plasma testosterone. The mechanism where by plasma pregnenolone and 17-OH-pregnenolone levels are elevated in patients with 21-hydroxylase deficiency is unknown, but the phenomenon of product inhibition is suggested as a possible explanation. As 17-OH-pregnenolone in plasma is almost entirely of adrenal origin, its measurement promises to be useful in the management of patients with congenital adrenal hyperplasia. Acute stimulation with ACTH caused negligible changes in the plasma levels of pregnenolone and 17-OH-pregnenolone and failed to distinguish between overly, appropriately, and under-treated patients. However, following repeated stimulation with repository ACTH, the steroid levels rose. These findings indicate limited adrenal responsiveness to ACTH following chronic glucocorticoid treatment of congenital adrenal hyperplasia, even in under-treated patients, and suggest that normal precursor steroid levels in plasma and normal 17-ketosteroid and pregnanetriol excretion can only be achieved by the suppression of total steroidogenesis to less than that occurring in normal subjects.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0021-972X
pubmed:author
pubmed:issnType
Print
pubmed:volume
42
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
918-25
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:178685-17-Ketosteroids, pubmed-meshheading:178685-17-alpha-Hydroxypregnenolone, pubmed-meshheading:178685-Adolescent, pubmed-meshheading:178685-Adrenal Hyperplasia, Congenital, pubmed-meshheading:178685-Adrenocortical Hyperfunction, pubmed-meshheading:178685-Adrenocorticotropic Hormone, pubmed-meshheading:178685-Adult, pubmed-meshheading:178685-Child, pubmed-meshheading:178685-Child, Preschool, pubmed-meshheading:178685-Clinical Trials as Topic, pubmed-meshheading:178685-Female, pubmed-meshheading:178685-Humans, pubmed-meshheading:178685-Hydrocortisone, pubmed-meshheading:178685-Hyperplasia, pubmed-meshheading:178685-Infant, pubmed-meshheading:178685-Male, pubmed-meshheading:178685-Pregnanetriol, pubmed-meshheading:178685-Pregnenolone, pubmed-meshheading:178685-Progesterone Reductase, pubmed-meshheading:178685-Steroid Hydroxylases, pubmed-meshheading:178685-Testosterone
pubmed:year
1976
pubmed:articleTitle
Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.